↓ Skip to main content

High-dose thiamine therapy for patients with type 2 diabetes and microalbuminuria: a randomised, double-blind placebo-controlled pilot study

Overview of attention for article published in Diabetologia, December 2008
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (94th percentile)
  • High Attention Score compared to outputs of the same age and source (96th percentile)

Mentioned by

news
1 news outlet
twitter
11 X users

Citations

dimensions_citation
138 Dimensions

Readers on

mendeley
120 Mendeley
citeulike
1 CiteULike
Title
High-dose thiamine therapy for patients with type 2 diabetes and microalbuminuria: a randomised, double-blind placebo-controlled pilot study
Published in
Diabetologia, December 2008
DOI 10.1007/s00125-008-1224-4
Pubmed ID
Authors

N. Rabbani, S. S. Alam, S. Riaz, J. R. Larkin, M. W. Akhtar, T. Shafi, P. J. Thornalley

Abstract

High-dose supplements of thiamine prevent the development of microalbuminuria in experimental diabetes. The aim of this pilot study was to assess whether oral supplements of thiamine could reverse microalbuminuria in patients with type 2 diabetes.

X Demographics

X Demographics

The data shown below were collected from the profiles of 11 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 120 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 1 <1%
Canada 1 <1%
Unknown 118 98%

Demographic breakdown

Readers by professional status Count As %
Student > Master 19 16%
Student > Bachelor 14 12%
Researcher 13 11%
Other 11 9%
Student > Ph. D. Student 10 8%
Other 29 24%
Unknown 24 20%
Readers by discipline Count As %
Medicine and Dentistry 33 28%
Agricultural and Biological Sciences 12 10%
Nursing and Health Professions 9 8%
Pharmacology, Toxicology and Pharmaceutical Science 9 8%
Biochemistry, Genetics and Molecular Biology 8 7%
Other 19 16%
Unknown 30 25%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 16. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 01 August 2023.
All research outputs
#2,253,004
of 25,249,294 outputs
Outputs from Diabetologia
#1,170
of 5,332 outputs
Outputs of similar age
#9,490
of 179,563 outputs
Outputs of similar age from Diabetologia
#2
of 29 outputs
Altmetric has tracked 25,249,294 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 91st percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 5,332 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 24.6. This one has done well, scoring higher than 78% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 179,563 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 94% of its contemporaries.
We're also able to compare this research output to 29 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 96% of its contemporaries.